Thank you for attending! Recordings will be available soon!

Simon Mainwaring

Founder & CEO
We First, Inc.

Simon Mainwaring is a brand futurist, speaker, author, podcaster, and columnist. He’s a Real Leaders’ Top 50 Keynote Speaker, MOMENTUM Top 100 Impact CEO, Featured Expert, a Jury Member at the Cannes Lions Festival and U.S. One Show for Sustainable Development, and Thinkers360 Top 50 Global Thought Leaders and Influencers on Climate Change. He is the founder/CEO of We First, an award-winning, strategic consultancy building purpose, sustainability, and impact initiatives for brands. We First is a Real Leaders’ Top 100 Impact Companies in the U.S. and a B Corp ‘Best For the World’ Honoree. Simon’s first book, We First is a New York Times bestseller and named Best Marketing Book of the Year by strategy+business. His new book, Lead With We is a Wall Street Journal bestseller, McKinsey Top Business Bestseller on Workplace & Culture, and a finalist for International Business Book of the Year. He hosts the influential Lead With We podcast, is a columnist for the CMO Network in Forbes, and provides C-Suite Advisory Services for leaders committed to transforming their business and our future.


Sessions
WORKSHOP
PACIFIC BALLROOM E
Track: Organizational Transformation & Governance

This session will host a candid discussion about internal company practices that have stood the test of time in terms of helping turn employees and top management into sustainability advocates and champions.... see more

Monday 14th October
10:00 AM - 12:00 PM
WORKSHOP
PACIFIC BALLROOM E
Track: Organizational Transformation & Governance

This insight-packed session will provide a compilation of best practices and advice on several key dimensions of sustainability-minded governance. The range of governance issues covered will include: putting purpose into practice in... see more

Monday 14th October
1:30 PM - 3:30 PM

Get

Updates

Want more news from SB’24 San Diego? Sign-up for the latest articles, speaker announcements, program developments, and more.